InvestorsHub Logo
icon url

kgromax

06/01/23 2:38 PM

#220697 RE: misiu143 #220696

Yet ClosetInvestor's opinions have been 99% correct over the last 5+ years.

Following his posts would have ensure a pretty nice return on capital

Looks like an excellent analyst to me of Cytodyn's current situation

... (big silence)...
LOL
Bearish
Bearish
icon url

djjazzyjeff

06/01/23 3:37 PM

#220699 RE: misiu143 #220696

You also said you wouldn't be surprised if the hold was lifted by March. It's June.
icon url

ClosetInvestor

06/01/23 6:07 PM

#220709 RE: misiu143 #220696

“This is your opinion only.”

Time will show , I will not be surprise with partnership in cancer relatively soon after hold removal.”

Over 2 years ago, in March of 2021, I opined that CD12 had failed based on NP’s wild and ridiculous “send to 100 FDAs” PR. The stock was $4.xx at the time of that PR.

What happened? CD12 failed and the stock dropped to $2. Now it’s .2689.

There is no pending partnership for cancer. The trials were a mix of different doses, different cancers and uncontrolled. They’ll need to complete a phase 2 and have clear data before any partnership is possible.

They’ll also need to clear the books of $65 million owed to Samsung. Yuck.